IEX •
Healthcare •
Biotechnology •
Quote as of 05/18/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization4.19 mln
Float0.64 mln
Earnings Date04/01/2026
Piotroski F-Score
2
/ 9
Weak
Relative Strength
0
/ 100
Severely lagging
Debt / Equity
-0.53
Negative equity
ROE
-32,523
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Artelo Biosciences is a US-based clinical-stage drug development company focused on treatments that work through the body's lipid-signaling systems. Its pipeline includes compounds targeting cancer-related appetite loss, nerve pain from chemotherapy, and conditions such as anxiety, depression, PTSD, and epilepsy. Founded in 2011 and headquartered in Solana Beach, California, the company was previously called Reactive Medical before rebranding in 2017.
